| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2021 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H75 | Director, 10% Owner | Sell | 3,887,500 | $16.40 | $63,755,000.00 | -6.1% | -12.7% | -66.7% | |
| May 27, 2021 | ORGO Organogenesis Holdings Inc. | Erani Dennis | 10% Owner | Sell | 9,106 | $18.97 | $172,740.82 | -0.7% | -12.7% | -66.7% | |
| May 27, 2021 | ORGO Organogenesis Holdings Inc. | Ades Alan A. | Director, 10% Owner | Sell | 3,887,500 | $16.40 | $63,755,000.00 | -6.1% | -12.7% | -66.7% | |
| May 27, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 20,811 | $36.84 | $766,699.64 | -0.5% | -2.6% | -10.8% | |
| May 27, 2021 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | - | Sell | 242,300 | $8.52 | $2,064,511.00 | -2.0% | -40.5% | -62.7% | |
| May 27, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 450 | $2.88 | $1,294.50 | +0.1% | -8.1% | -29.1% | |
| May 27, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 450 | $2.88 | $1,294.50 | - | -8.1% | -29.1% | |
| May 26, 2021 | BHC Bausch Health Companies Inc. | Wechsler Amy B | Director | Sell | 11,037 | $31.79 | $350,811.05 | -10.1% | -10.3% | -69.1% | |
| May 25, 2021 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 14,500 | $175.45 | $2,544,026.00 | -17.6% | +17.0% | -7.2% | |
| May 25, 2021 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 3,139 | $56.48 | $177,290.72 | -17.9% | +12.5% | -40.4% | |
| May 25, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 21,541 | $35.93 | $773,888.84 | -0.5% | -0.8% | -9.3% | |
| May 24, 2021 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President And Interim CEO | Sell | 1,716 | $12.25 | $21,021.00 | -0.3% | +7.0% | -9.6% | |
| May 24, 2021 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 516 | $12.25 | $6,321.00 | -0.1% | +7.0% | -9.6% | |
| May 24, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 7,329 | $202.27 | $1,482,405.07 | - | +33.7% | +54.4% | |
| May 24, 2021 | IRWD Ironwood Pharmaceuticals Inc | Shetzline Michael67 | CMO, SVP &Head Of Drug Devt. | Sell | 2,077 | $12.25 | $25,443.25 | -1.0% | +7.0% | -9.6% | |
| May 24, 2021 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 100,000 | $20.22 | $2,021,620.00 | +2.3% | -31.9% | -71.4% | |
| May 24, 2021 | BCRX Biocryst Pharmaceuticals Inc | Abercrombie George B68 | Director | Sell | 6,667 | $13.90 | $92,671.30 | -69.0% | +11.0% | -37.1% | |
| May 21, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Drape Eric51 | Executive VP Global Operations | Sell | 40,000 | $11.01 | $440,320.00 | -54.7% | -16.3% | -23.1% | |
| May 21, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 92,740 | $200.58 | $18,602,006.28 | - | +35.7% | +51.6% | |
| May 21, 2021 | CVSI Cv Sciences, Inc. | Maroon Joseph C Md | Director | Buy | 50,000 | $0.38 | $19,000.00 | +6.7% | - | - | |
| May 21, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 18,746 | $35.50 | $665,439.32 | -0.9% | -4.8% | -12.0% | |
| May 21, 2021 | VTRS Viatris Inc | Cornwell W Don | Director | Buy | 2,000 | $15.71 | $31,414.95 | +26.7% | -3.8% | -21.0% | |
| May 20, 2021 | ASRT Assertio Holdings, Inc. | Peisert Daniel A.54 | President And CEO | Buy | 15,909 | $1.54 | $24,499.86 | +21.6% | -36.3% | +111.4% | |
| May 20, 2021 | GSK Gsk Plc | Glaxosmithkline Plc | 10% Owner | Sell | 32,005,260 | $12.25 | $392,064,435.00 | -100% | +8.0% | +17.8% | |
| May 20, 2021 | HROW Harrow, Inc. | Lindstrom Richard L Md65 | - | Sell | 10,000 | $10.75 | $107,500.00 | -10.0% | -12.9% | -40.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.